09/30/2026 | Press release | Distributed by Public on 09/30/2026 05:13
|
•
|
Following deliberate portfolio shaping over the last several years, The Cigna Group is strategically positioned where health care costs are concentrating with multiple avenues for growth
|
|
•
|
Announces "Lead to One" vision, unifying all colleagues around delivering personalization at scale to improve affordability and the patient experience
|
|
•
|
Distinct, industry-leading capabilities in complex care, powered by clinical expertise, data, technology and AI
|
|
•
|
Announces $3B multi-year modernization and productivity initiatives to fuel performance
|
|
•
|
Reaffirms 2026 full-year financial guidance and provides long-term financial growth target of 10-14% adjusted EPS CAGR through 2030
|
|
•
|
Deliver core growth: Build on the strong foundation of a deliberately shaped portfolio - including Cigna Healthcare and Evernorth's Specialty & Care Services and Pharmacy Benefit Services - to drive growth.
|
|
•
|
Leverage distinct capabilities: Apply industry-leading complex care capabilities, enabled by clinical expertise, data, technology and AI.
|
|
•
|
Execute with discipline: Maintain a clear vision, consistent execution, operational excellence, a culture of innovation and disciplined capital stewardship.
|
|
•
|
Evernorth Specialty & Care Services: Supports more than one million patients with complex conditions and delivers more than 8 million prescriptions annually, combining deep clinical expertise, nationwide provider and distribution capabilities, and personalized support models that improve access, adherence, and outcomes. This combination has established Evernorth as a trusted partner to patients, providers, health systems, and drug manufacturers.
|
|
•
|
Cigna Healthcare: Delivers more personalized and proactive experiences across the full spectrum of patient requirements, from identifying emerging oncology needs earlier to providing AI-enabled navigation and advocacy support.
|
|
•
|
Evernorth Pharmacy Benefit Services: Integrates pharmacy benefits, clinical insights, and supply chain expertise to improve affordability, support better adherence, and drive better outcomes at scale.
|
|
•
|
Consolidated Adjusted Revenues of ~$280 billion
|
|
•
|
Consolidated Adjusted EPS of at least $30.45
|
|
•
|
Evernorth Health Services pre-tax adjusted income from operations of at least $6.90 billion
|
|
•
|
Cigna Healthcare pre-tax adjusted income from operations of at least $4.55 billion
|
|
•
|
Medical care ratio of 83.7% to 84.7%
|
|
•
|
10-14% Adjusted EPS CAGR
|
|
•
|
~$50 billion in cumulative operating cash flow
|